Evidence map›Paper›PMID 40903880›Full record

ArticleDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2025

Vendor-Agnostic Vision Transformer-Based Artificial Intelligence for Peroral Cholangioscopy: Diagnostic Performance in Biliary Strictures Compared With Convolutional Neural Networks and Endoscopists.

Ryosuke Sato, Kazuyuki Matsumoto, Masahiro Tomiya, Takayoshi Tanimoto, Akimitsu Ohto, Kentaro Oki, Satoshi Kajitani, Tatsuya Kikuchi, Akihiro Matsumi, Kazuya Miyamoto and 6 more

Abstract readComparative Study
In one paragraph

Article in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Advances in Diagnosis and Treatment With Cholangiopancreatoscopy.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ryosuke SatoDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.ORCID https://orcid.org/0000-0002-5368-6347
Kazuyuki MatsumotoDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.ORCID https://orcid.org/0000-0002-5102-7452
Masahiro TomiyaHealthcare Solutions Division, Ryobi Systems Co., Ltd, Okayama, Japan.
Takayoshi TanimotoHealthcare Solutions Division, Ryobi Systems Co., Ltd, Okayama, Japan.
Akimitsu OhtoHealthcare Solutions Division, Ryobi Systems Co., Ltd, Okayama, Japan.
Kentaro OkiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Satoshi KajitaniDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.ORCID https://orcid.org/0009-0003-5340-3057
Tatsuya KikuchiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Akihiro MatsumiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Kazuya MiyamotoDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Yuki FujiiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Daisuke UchidaDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Koichiro TsutsumiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Shigeru HoriguchiDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Yoshiro KawaharaDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Motoyuki OtsukaDepartment of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.

Funding

Japan Agency for Medical Research and Development 25hma922034h0001
6 · The paper itself

Abstract

objectivesAccurate diagnosis of biliary strictures remains challenging. This study aimed to develop an artificial intelligence (AI) system for peroral cholangioscopy (POCS) using a Vision Transformer (ViT) architecture and to evaluate its performance compared to different vendor devices, conventional convolutional neural networks (CNNs), and endoscopists.

methodsWe retrospectively analyzed 125 patients with indeterminate biliary strictures who underwent POCS between 2012 and 2024. AI models including the ViT architecture and two established CNN architectures were developed using images from CHF-B260 or B290 (CHF group; Olympus Medical) and SpyScope DS or DS II (Spy group; Boston Scientific) systems via a patient-level, 3-fold cross-validation. For a direct comparison against endoscopists, a balanced 440-image test set, containing an equal number of images from each vendor, was used for a blinded evaluation.

resultsThe 3-fold cross-validation on the entire 2062-image dataset yielded a robust accuracy of 83.9% (95% confidence interval (CI), 80.9-86.7) for the ViT model. The model's accuracy was consistent between CHF (82.7%) and Spy (86.8%, p = 0.198) groups, and its performance was comparable to the evaluated conventional CNNs. On the 440-image test set, the ViT's accuracy of 78.4% (95% CI, 72.5-83.8) was comparable to that of expert endoscopists (82.0%, p = 0.148) and non-experts (73.0%, p = 0.066), with no statistically significant differences observed.

conclusionsThe novel ViT-based AI model demonstrated high vendor-agnostic diagnostic accuracy across multiple POCS systems, achieving performance comparable to conventional CNNs and endoscopists evaluated in this study.

Indexed as

Artificial IntelligenceCholestasisEndoscopy, Digestive SystemNeural Networks, ComputerAgedConstriction, PathologicConvolutional Neural NetworksFemaleHumansMaleMiddle AgedRetrospective Studiesartificial intelligencebile duct neoplasmscholangioscopycomputer‐assisted diagnosisvision transformer

Identifiers

PMID40903880
PMCPMC12702826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.